Search results
Results from the WOW.Com Content Network
American protein chemist at Harvard, very influential in protein research, and author (with Edwin Cohn) of Proteins, Amino Acids and Peptides. Member Natl. Acad. Sci. USA. Konstantin Efetov (b. 1958). Ukrainian biochemist at Crimea State Medical University, known for work in molecular immunology, evolutionary biology, and biosystematics.
Boyle, in this book, became the first to argue that experiment should form the basis of all theory, a common practice in chemistry today. He also expounded on a rudimentary atomic theory and the existence of chemical elements beyond the classic earth, fire, air, and water. [5]
Tour was awarded the Royal Society of Chemistry's Centenary Prize for innovations in materials chemistry with applications in medicine and nanotechnology. [49] Tour was inducted into the National Academy of Inventors in 2015. [50] [51] [52] He was named among "The 50 most Influential Scientists in the World Today" by TheBestSchools.org in 2014 ...
Pierre Macquer (1718–1784), influential French chemist; Rudolph A. Marcus (born 1923), 1992 Nobel Prize in Chemistry; Jacob A. Marinsky (1918–2005), American chemist, co-discovered the element promethium; Jean Charles Galissard de Marignac (1817–1894), Swiss chemist, discovered ytterbium and co-discovered gadolinium
Physical chemistry: Mikhail Lomonosov (1711–1765) The first to read lectures in physical chemistry and coin the term (1752). Jacobus van 't Hoff (1852–1911) Jacobus van 't Hoff is considered one of the founders of the discipline of physical chemistry. His work helped found the discipline as it is today. [71] [72] [73] Svante Arrhenius (1859 ...
[177] [178] His description reads: "A remarkably versatile scientist, structural chemist Linus Pauling (1901–1994) won the 1954 Nobel Prize in Chemistry for determining the nature of the chemical bond linking atoms into molecules. His work in establishing the field of molecular biology; his studies of hemoglobin led to the classification of ...
The objective of the study was to assess the effect of a cholesterol-lowering drug called simvastatin on mortality and morbidity in group of 4444 patients with coronary heart disease, aged between 35 and 70 years. The patients presented with moderate hypercholesterolemia between 5.5 and 8.0 mmol/L. The results of the trial showed that ...
His honors include selection as the most influential physician-executive in the United States (Modern Healthcare magazine, 2015), the John M. Eisenberg award (nation’s top honor in patient safety, 2004), and election to the National Academy of Medicine (2020). He is also a Master of the American College of Physicians.